HRT Financial’s BioTelemetry, Inc. BEAT Stock Holding History

HRT Financial’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,512	Closed	-$325K	–	3431
2020 Q4	$325K	Sell	4,512 -7,732	-63%	-$405K	0.01%	1239
2020 Q3	$558K	Buy	+12,244	New	+$512K	0.02%	821
2020 Q1	–	Sell	-5,184	Closed	-$240K	–	1595
2019 Q4	$240K	Buy	+5,184	New	+$224K	0.01%	858

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

HRT Financial's BEAT Position: Q1 2021 in Review

HRT Financial sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 4,512 shares — an estimated $325K sold.

HRT Financial first reported a position in BEAT in Q4 2019 and held it in 3 quarters. The position peaked at $558K in Q3 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

HRT Financial reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
HRT Financial sold 4,512 BioTelemetry, Inc. shares in Q1 2021, an estimated $325K.
HRT Financial first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 3 quarters.
HRT Financial's BioTelemetry, Inc. position peaked at $558K in Q3 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on HRT Financial's 13F filing for Q1 2021, filed 17 May 2021.